Peripheral Neuropathy and Toxic Chemical Exposure
Peripheral neuropathy—damage to peripheral nerves causing numbness, tingling, weakness, and pain—has well-established occupational chemical causes. Emerging research implicates PFAS compounds in peripheral nerve injury through myelin disruption, axonal transport interference, and neuroinflammatory mechanisms.
PFAS Effects on Schwann Cells and Myelin
PFAS accumulate in peripheral nerve Schwann cells that produce and maintain myelin sheaths protecting nerve axons. PFAS-induced oxidative stress and lipid metabolism disruption in Schwann cells impairs myelin production and maintenance, potentially causing demyelinating neuropathy similar to occupational heavy metal neurotoxicity.
Sensory vs. Motor Neuropathy Patterns
Early PFAS-associated peripheral neuropathy may preferentially affect small-fiber sensory nerves—producing burning, tingling, and temperature sensitivity abnormalities—before affecting large fiber motor function. Small fiber neuropathy is underdiagnosed and requires specialized skin biopsy or quantitative sensory testing for detection, which may explain why PFAS neuropathy is not yet well characterized in clinical populations.
Neurological Evaluation in PFAS Communities
Neurologists evaluating idiopathic peripheral neuropathy in PFAS-contaminated communities should consider environmental exposure assessment. Skin punch biopsy for intraepidermal nerve fiber density and nerve conduction studies with quantitative sensory testing provide the most sensitive assessment for early PFAS-associated peripheral nerve injury